VentriPoint Diagnostics (TSE:VPT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
VentriPoint Diagnostics Ltd. has announced the sale of its second VMS+ unit to Duke University Health Center, a leading heart-care institution, for advanced heart scans using AI technology. This technology, which has been successfully used at Duke Children’s Hospital for two years, provides MRI-quality heart measurements quickly and at a lower cost. The VMS+ system will now support the adult cardiology clinic, furthering the study and implementation of VentriPoint’s innovations in heart health diagnostics.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.